TY  - GEN
AU  - Ji,Sang Hoon
AU  - Park,Young Suk
AU  - Lee,Jeeyun
AU  - Lim,Do Hyoung
AU  - Park,Byeong-Bae
AU  - Park,Keun Woo
AU  - Kang,Jung Hun
AU  - Lee,Se-Hoon
AU  - Park,Joon Oh
AU  - Kim,Kihyun
AU  - Kim,Won Seog
AU  - Jung,Chul Won
AU  - Im,Young-Hyuck
AU  - Kang,Won Ki
AU  - Park,Keunchil
TI  - Phase II study of irinotecan, 5-fluorouracil and leucovorin as first-line therapy for advanced colorectal cancer
SN  - 0368-2811
PY  - 2005///0616
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Camptothecin
KW  - administration & dosage
KW  - Colonic Neoplasms
KW  - drug therapy
KW  - Disease-Free Survival
KW  - Drug Administration Schedule
KW  - Female
KW  - Fluorouracil
KW  - Humans
KW  - Irinotecan
KW  - Leucovorin
KW  - Leukopenia
KW  - chemically induced
KW  - Liver Neoplasms
KW  - secondary
KW  - Lung Neoplasms
KW  - Lymphatic Metastasis
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Middle Aged
KW  - Rectal Neoplasms
KW  - Survival Analysis
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
UR  - https://doi.org/10.1093/jjco/hyi061
ER  -